Plexxikon Inc. v. Novartis Pharmaceuticals Corporation

Good Law
United States District Court, Northern District of CaliforniaMarch 20, 20204:17-cv-04405California2,424 words

Opinion

trial_court Opinion

1 2 3 4 UNITED STATES DISTRICT COURT 5 NORTHERN DISTRICT OF CALIFORNIA 6 7 PLEXXIKON INC., Case No. 17-cv-04405-HSG

8 Plaintiff, ORDER GRANTING IN PART AND

DENYING IN PART MOTION TO

9 v. STRIKE DEFENDANT’S DAUBERT

MOTIONS

10 NOVARTIS PHARMACEUTICALS CORPORATION, Re: Dkt. No. 236 11 Defendant. 12 13 Pending before the Court is Plaintiff Plexxikon Inc.’s motion to strike Defendant Novartis 14 Pharmaceutical Corporation’s Daubert motions. See Dkt. No. 236. The Court held a hearing on 15 November 1, 2019. Dkt. No. 337. As indicated during the hearing, and as detailed further below, 16 the Court GRANTS IN PART and DENIES IN PART the motion. 17 I. DISCUSSION 18 Plaintiff challenges the timeliness of Defendant’s four Daubert motions, filed on June 6, 19 2019. See Dkt. Nos. 200, 202, 204, 206. In the alternative, Plaintiff seeks to strike a declaration 20 filed in support of one of the Daubert motions. See Dkt. No. 200-1. The Court addresses each 21 argument in turn. 22 A. Motion to Strike Daubert…

Sign in to read the full opinion

Create a free account to read the complete opinion text, citation history, and good-law status for this case.